Our top pick for
Building a portfolio

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Qudian Inc is a credit services business based in the US. Qudian shares (QD) are listed on the NYSE and all prices are listed in US Dollars. Qudian employs 947 staff and has a market cap (total outstanding shares value) of USD$342.5 million.
Our top pick for
Building a portfolio
Our top pick for
Beginners
Our top pick for
Casual investors
Latest market close | USD$1.31 |
---|---|
52-week range | USD$1.21 - USD$5.09 |
50-day moving average | USD$1.4129 |
200-day moving average | USD$1.5864 |
Wall St. target price | USD$1.55 |
PE ratio | 1.667 |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | USD$1.053 |
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $1.31 from 2020-12-09
1 week (2021-01-10) | N/A |
---|---|
1 month (2020-12-21) | 6.50% |
3 months (2020-10-17) | N/A |
6 months (2020-07-17) | N/A |
1 year (2020-01-17) | N/A |
---|---|
2 years (2019-01-17) | N/A |
3 years (2018-01-17) | N/A |
5 years (2016-01-17) | N/A |
Valuing Qudian stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Qudian's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Qudian's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 2x. In other words, Qudian shares trade at around 2x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Gross profit TTM | USD$5.6 billion |
---|---|
Return on assets TTM | 8.95% |
Return on equity TTM | 7.54% |
Profit margin | 13.11% |
Book value | $5.054 |
Market capitalisation | USD$342.5 million |
TTM: trailing 12 months
There are currently 10.9 million Qudian shares held short by investors – that's known as Qudian's "short interest". This figure is 15.3% down from 12.9 million last month.
There are a few different ways that this level of interest in shorting Qudian shares can be evaluated.
Qudian's "short interest ratio" (SIR) is the quantity of Qudian shares currently shorted divided by the average quantity of Qudian shares traded daily (recently around 2.6 million). Qudian's SIR currently stands at 4.14. In other words for every 100,000 Qudian shares traded daily on the market, roughly 4140 shares are currently held short.
However Qudian's short interest can also be evaluated against the total number of Qudian shares, or, against the total number of tradable Qudian shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Qudian's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Qudian shares in existence, roughly 40 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable Qudian shares, roughly 0 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Qudian.
Find out more about how you can short Qudian stock.
We're not expecting Qudian to pay a dividend over the next 12 months.
Over the last 12 months, Qudian's shares have ranged in value from as little as $1.21 up to $5.09. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Qudian's is 1.1762. This would suggest that Qudian's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Qudian Inc. provides online small consumer credit products in the People's Republic of China. It uses big data-enabled technologies, including artificial intelligence and machine learning to transform the consumer finance experience. The company offers small credit products, such as cash credit products; merchandise credit products to finance borrowers' direct purchase of merchandise offered on its marketplace on installment basis; and budget auto financing products. In addition, it operates a platform for loan recommendations and referrals. Qudian Inc. was founded in 2014 and is headquartered in Xiamen, the People's Republic of China.
Everything we know about the NLS Pharmaceutics Ltd IPO, plus information on how to buy in.
Everything we know about the GitLab IPO, plus information on how to buy in.
Everything we know about the Longeveron LLC IPO, plus information on how to buy in.
Everything we know about the Signify Health Inc IPO, plus information on how to buy in.
Everything we know about the Biophytis SA IPO, plus information on how to buy in.
Everything we know about the NexImmune Inc IPO, plus information on how to buy in.
Everything we know about the Adagene Inc IPO, plus information on how to buy in.
Everything we know about the Cloopen Group Holding Limited IPO, plus information on how to buy in.
Everything we know about the Decipher Biosciences Inc IPO, plus information on how to buy in.
Everything we know about the Proterra IPO, plus information on how to buy in.